Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 30
- Exclusivities
- 2
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| capsule | 1 |
| tablet, film coated | 1 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| array biopharma inc. | 2 |
Exclusivity
Patents and exclusivities
30| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7777050 | MEKTOVIbinimetinib | substance, product | Mar 2027 |
| 8946250 | BRAFTOVIencorafenib | substance, product | Jul 2029 |
| 8541575 | BRAFTOVIencorafenib | substance, product | Feb 2030 |
| RE49556 | BRAFTOVIencorafenib | substance, product | Feb 2030 |
| 10005761 | BRAFTOVI, MEKTOVIbinimetinib; encorafenib | use | Aug 2030 |
| 9593099 | BRAFTOVIencorafenib | substance | Aug 2030 |
| 9593100 | BRAFTOVIencorafenib | product | Aug 2030 |
| 9850229 | BRAFTOVI, MEKTOVIbinimetinib; encorafenib | use | Aug 2030 |
| 9850230 | BRAFTOVIencorafenib | use | Aug 2030 |
| 9314464 | BRAFTOVI, MEKTOVIbinimetinib; encorafenib | use | Jul 2031 |
| 10258622 | BRAFTOVIencorafenib | use | Nov 2032 |
| 9387208 | BRAFTOVIencorafenib | product | Nov 2032 |
| 9763941 | BRAFTOVIencorafenib | use | Nov 2032 |
| 9474754 | BRAFTOVIencorafenib | use | Aug 2033 |
| 9562016 | MEKTOVIbinimetinib | substance, product | Oct 2033 |
| 9598376 | MEKTOVIbinimetinib | use | Oct 2033 |
| 9980944 | MEKTOVIbinimetinib | use | Oct 2033 |
| Product | Exclusivity | Until |
|---|---|---|
| BRAFTOVIENCORAFENIB | ODE-445 Orphan drug | Oct 2030 |
| MEKTOVIBINIMETINIB | I-928 New indication | Oct 2026 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| BRAFTOVI | Encorafenib | capsule, oral | 70255-025NDA |
| MEKTOVI | BINIMETINIB | tablet, film coated, oral | 70255-010NDA |
Enquiry
Common questions
- Is Array BioPharma Inc. FDA approved?
- Array BioPharma Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Array BioPharma Inc. make?
- 2 products are listed under Array BioPharma Inc. in the openFDA NDC Directory, most often as capsule; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.